PAR 4.76% 20.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-720

  1. 3,791 Posts.
    lightbulb Created with Sketch. 1554
    No more buying while this clown show continues, tapped out for this level of mismanagement, how much more money do they expect shareholders to put in to fund their project?

    Changed my sentiment to none, the drug has enormous potential, but Rennie has no idea how to run a company without proper oversight. All these timelines will shift and watch him say nothing and then drop a clanger out of school.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.